Mary E. Sears

438 citations
10 papers · 363 indexed · h-index 6

Impact in

    • Breast Cancer Treatment Studies
  • Oncology top 10%
    • Cancer Treatment and Pharmacology
    • HER2/EGFR in Cancer Research

Papers in

    • Breast Cancer Treatment Studies 4
    • Cancer Treatment and Pharmacology 4
    • Cancer Risks and Factors 2
    • Neutropenia and Cancer Infections 1

Mary E. Sears

10 papers receiving 320 citations

Peers

Mary E. Sears
Comparison fields: 5 of 47
  • Cancer Research 189
  • Oncology 262
  • Dermatology 29
  • Pathology and Forensic Medicine 47
  • Genetics 68
Replace E Ghislandi with:
E Ghislandi Italy
J Guerrin France
H Robertshaw United Kingdom
Frank C. Schell United States
Leena Helle Finland
健二郎 青儀
Delano M. Pfeifle United States
Jean-Pierre Ferrière France
S Wolff United States
Federico Castiglione Italy
Mary E. Sears relative to E Ghislandi Italy E Ghislandi's profile →
Citations per field
00.5×1.5×2.0×
E Ghislandi · 1×
Citations per year

Countries citing papers authored by Mary E. Sears

Since Specialization
Citations

This map shows the geographic impact of Mary E. Sears's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary E. Sears with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary E. Sears more than expected).

Fields of papers citing papers by Mary E. Sears

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary E. Sears. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary E. Sears. The network helps show where Mary E. Sears may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Mary E. Sears, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mary E. Sears Line = papers co-authored together Mary E. Sears links everyone, so they are left out of the graph.

All Works

10 of 10 papers shown
#Work
1 198410
2 198295
3 198113
4 19802
5 197969
6 19784
7
Phase II trial with bleomycin, CCNU, and streptozotocin in patients with metastatic cancer of the breast.
19772
8 1976148
9 19683
10 195817

About Mary E. Sears

Mary E. Sears is a scholar working on Cancer Research, Oncology, Genetics, Hepatology and Genetics, having authored 10 papers that have together received 363 indexed citations. Recurring topics across this work include Estrogen and related hormone effects (4 papers), Breast Cancer Treatment Studies (4 papers), Cancer Treatment and Pharmacology (4 papers), Cancer Risks and Factors (2 papers), Cancer therapeutics and mechanisms (1 paper), Neutropenia and Cancer Infections (1 paper), Pesticide Residue Analysis and Safety (1 paper) and Antifungal resistance and susceptibility (1 paper). The work is most often cited by research in Cancer Research (189 citations), Oncology (262 citations), Dermatology (29 citations), Pathology and Forensic Medicine (47 citations) and Genetics (68 citations). Mary E. Sears has collaborated with scholars based in United States, Canada and Japan. Frequent co-authors include Pierre R. Band, George P. Canellos, Samuel G. Taylor, Stuart Pocock, William McGuire, David P. Byar, Douglass C. Tormey, Rebecca Gelman, William D. DeWys and Charles P. Perlia. Their work appears in journals such as Cancer, Digestive Diseases and Sciences, Breast Cancer Research and Treatment, Blood and Medical and Pediatric Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026